報價延遲最少15分鐘:2025/05/15 10:44 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
29.73 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-3.01/-4.83
|
|
企業價值
2.29B
|
| 資產負債 |
|
每股賬面淨值
9.86
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
0.00
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/15 10:44 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain. |